Featured
Decoy Therapeutics, Inc. Announces Up to $21 Million Private Placement Financing
Read ArticleSalarius Pharmaceuticals Merger Partner, Decoy Therapeutics, Announces its Novel Inhibitors Show Promising In Silico Activity Against Measles and Related Viruses
Read ArticleSalarius Pharmaceuticals and Decoy Therapeutics Announce Definitive Merger Agreement
Read ArticleCEO Rick Pierce Receives JLABS Community Member of the Year Award
Read ArticleDecoy Joins GitHub for Startups Program, Providing a Suite of Software Resources for Their Developers on GitHub
Read ArticleDecoy Accepted Into NVIDIA Inception Program to Build Their AI Drug Discovery Platform with NVIDIA GPUs
Read ArticleJohnson & Johnson Innovation and the Biomedical Advanced Research and Development Authority (BARDA) Name Awardees in the BLUE KNIGHT™ Resident QuickFire Challenge: Partnering for Preparedness
Read ArticleYou have reached the end of the articles.
